Additional European Equity News

GSK (GSK LN) - Confirms US settlement of CureVac/BioNTech mRNA litigation; CureVac will make an upfront settlement of USD 370mln to GSK. (Newswires) 

Kingspan (KGP ID) - H1 (EUR): Revenue 4.5bln, +8% Y/Y. Interim dividend 26.3c/shr, in-line with prior year. Notes that co. has caught up on a slow start to the year as activity levels firmed. Expects FY trading profit approx. 5% ahead of last year. (Newswires)